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Many animals, man included, live in areas providing insuffi-
cient iodine (I) for optimal health. Degrees of I deficiency (ID)
vary frommild-moderate to very severe, with quali- and quan-
titatively different negative consequences. To understand the
mechanisms involved in adaptation to different grades of ID,
we fed rats a low-iodine diet, plus additions resulting in a
250-fold range of I daily available to the thyroid, ranging from
5 g (adequate) down to 0.02 g I. We measured thyroid
weight, total I, T4, T3, and type I 5 iodothyronine deiodinase
(D1) activity, TSH, T4, free T4, and T3 in plasma, T4 and T3 in
11 tissues, and two 5 deiodinase isoenzymes in four. TSH-
independent thyroid autoregulation plays an important role
in addition to TSH-dependent mechanisms in the adaptation
to ID, avoiding a decrease of T3 in plasma and most tissues,
despite a marked decrease of plasma T4, whereas extrathy-
roidal responses of D2 mitigate T3 deficiency in tissues in
which T3 is mostly generated from T4. We focused onmild and
moderate ID, the least investigatedexperimentally, despite its
current frequency in industrialized countries. The novel and
important finding of our study is that thyroid status cannot be
defined for the animal as a whole: at all grades of ID, T3 is
simultaneously elevated, normal, and low in different tissues.
Present findings in mild-moderate ID draw attention to the
importance, for man, of the resulting hypothyroxinemia that
may affect mental functions and neurodevelopment of the
inhabitants, even when they do not have the increased TSH
or clinical hypothyroidism, often wrongly attributed to them.
(Endocrinology 147: 2098–2108, 2006)
IODINE (I) IS a prerequisite for the synthesis of thyroidhormones, T4 and T3. Although relatively abundant in
sea water, it is often very scarce in terrestrial areas of the
world, inwhich animals have developed a highly specialized
structure, the thyroid follicle, to adapt to situations in which
the supply of this element is inadequate to meet thyroid
hormone requirements. The thyroid is optimized for the
efficient use and storage of I in the form of I-containing
compounds and for its intrathyroidal recycling, as a result of
which severe systemic deficiency of T3 is prevented, even
during relatively long periods of I deficiency (ID). A chronic
and severe ID might, however, lead to a situation in which
compensatory autoregulatory mechanisms can no longer
avoid a decrease in T4 and T3 secretion, and the organism
might suffer the ensuing negative consequences.
Today ID is still the single most important cause of pre-
ventable mental defects and cerebral palsy. It has been es-
tablished that more than 1 billion people are living in con-
ditions of chronic ID of varying degrees and are at risk of
suffering some, or all, of the various ensuing ID disorders
(IDDs) (1, 2). Their severity and irreversibility in man de-
pends on both the degree of the ID and the period during
development in which it is suffered. An adequate supply of
I to children and pregnant women are now considered basic
human rights.
The epidemiological, clinical, and biochemical findings
reported fromdifferent ID areas are quali- and quantitatively
heterogeneous. Definition of different grades of ID (grade I,
mild; grade II, moderate; grade III, severe) has been most
helpful in clarifying apparently conflicting reports from dif-
ferent regions (3). Although themost severe irreversible IDD,
such as the birth of neurological cretins, are usually found in
areas with severe (grade III) ID (4), impaired mental func-
tions are frequently found in the general population of even
mild to moderate ID areas (5).
Most of our present understanding of the adaptation of
human adults to chronic ID has been derived from experi-
mental models that limited the I intake of rats. Such studies
have usually involved comparison of results from animals on
a low-iodine diet (LID) with those from rats receiving the
same diet supplementedwith enough I tomeet physiological
thyroid hormone requirements or eating the stock diet (i.e.
Refs. 6–13). (For other related references, see supplemental
data published on The Endocrine Society’s Journals Online
Web site at http://endo.endojournals.org.) It is often difficult
to compare results because the nutritional composition and
I content of the various LID diets differ or are often not even
reported and so do the sex and strain of the animals. Few of
these previous studies have involved graded degrees of ID,
measured the concentrations of T4 and T3 in more than a few
selected tissues, or evaluated some parameter of thyroid
hormone action other than serum TSH. Despite this, such
studies have permitted identification of many, but not all, of
the intra- and extrathyroidal mechanisms involved in the
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response to ID,most of which cannot be investigated directly
in man for obvious constraints.
We want to point out that the experimental design used
here aimed at a difference in the amount of I available to the
thyroid as the single controlled variable between groups. It
should be an adequate model for inhabitants of areas in
which ID is the sole cause of goiter and thyroid tissue is
functionally unaffected, even in the neurological cretin. It is
not, however, an appropriate model for those ID areas in
which other nutritional or environmental factors may lead to
thyroid necrosis, primary hypothyroidism, and myxedem-
atous cretinism, such as seen in central Africa (14).
The aimof the present studywas to assess the relative roles
of intra- an extrathyroidal mechanisms in the response of
individual tissues to different grades of chronic ID, frommild
to moderate, to severe and very severe, with special focus on
the concentrations of T3. These were measured in a larger
number of tissues than previously studied over such a wide
range of ID. Although the T3 concentration was taken as an
index of possible thyroid hormone effectiveness at the indi-
vidual tissue level (15), some biological end points of thyroid
hormone action, other than circulating TSH, were also mea-
sured in selected tissues. The present approach shows that
the thyroid status of ID rats cannot be defined for the animal
as awhole because it is eminently tissue specific: at all grades
of ID, elevated, normal, and low concentrations of T3 are
simultaneously found in different tissues of the same animal.
Materials and Methods
Experimental design
Young adult female Wistar rats were used. They were housed under
humane conditions, with alternating 12-h light, 12-h dark cycles and at
22–24 C, under veterinary control according to European Community
guidelines and after approval by the ethics committee of our institution.
They were fed a stock pelleted diet for rats (Sandermus; Sanders, S.A.,
Barcelona, Spain)with an I content varying between 0.15 and 0.35g I/g,
which would provide 3–7 g I per day per rat (assuming a daily food
intake of 20 g). When they were approximately 50 d of age and weighed
120–150 g, they were switched from the stock diet to a diet with a very
low iodine content (LID) and given 1% KClO4 as drinking water for 1
wk to block further uptake of circulating iodide and accelerate depletion
of thyroid stores and I-containing compounds (16). This treatment min-
imized previous differences between animals. From then on, animals
were separated into different groups of five to six animals each and fed
the different diets described for experiments A and B.
Although we prepare the LID with components obtained from the
same commercial sources, its final I content is variable over time. To
ensure that at least one experimental group is severely ID, we often
include animals fed LID supplemented with very low amounts of
KClO4, at a concentration of 0.005% (LID group) (17, 18). This concen-
tration is 200 times lower that that used during the initial week before
separating the animals into different experimental groups. The purpose
is to decrease the availability to the thyroid of the small amounts of I
present in the LID and generated during intra-thyroid I recycling.
The LID was prepared by mixing thoroughly 6 kg corn flour (Pro-
ductos Hercosa, Barcelona, Spain), 2.5 kg wheat gluten (Herman Kro¨ner
GMBH, Ibbenbu¨rn, Germany), 1 kg brewer’s yeast (Vitalevor, Stras-
bourg-Neuhof, France), 0.15 kg NaCl, and 0.15 kg CaCO3 (Carlo Erba,
Milano, Italy). Sufficient amounts were prepared to cover a complete
experiment with the same batch. Daily rations were prepared by mixing
the dry LID with distilled water containing the different additions
(KClO4 or KI solutions) in a proportion of 0.7:1.0 (water-dry LID) and
dividing it into individual aliquots, which were kept frozen until use.
Experiment A. A preliminary experiment was performed to investigate
whether these small amounts of KClO4 (0.005%) would exert per se
effects on thyroid hormone economy other than impairing the uptake of
the minute amounts of I contained in the LID and intrathyroid I recy-
cling. For this, two groups of six animals eachwere fed LID (LID groups)
and two other groups LID supplemented with KI (LID I groups). One
each of these two groups received LID  0.005% KClO4: LID and LID
 I groups, respectively. The amount of KI was such that a daily intake
of 20 g of the LID  I mixture would provide 10 g I per animal.
Experiment B. This comprised five groups of five animals each that drank
distilled water and were fed the basic LID diet with the additions
specified in Table 1.
The I content of the LID diet itself was below the limit of detection
of the analytical procedure used to determine I in food (9).Wemeasured
the 24-h urinary I excretion of LID and LID rats during 5 consecutive
days. Mean values ( sem) were 0.052  0.012 and 0.083  0.009 g,
respectively. Although these results indicated that the amount of I in-
gested daily by animals on LID or LIDwas 0.052 0.012g, the amount
actually available to the thyroid of the LID animals was 0.031 g less,
namely 0.021 g I. Table 1 shows the estimated I intakes of the different
groups; they are merely tentative because neither the amount of food
ingested individually nor the fecal excretion of I-containing compounds
was measured. The amount of I available to the thyroids of the different
groups of rats appeared to differ 100-fold or more between the two
extreme groups (LID vs. LID  5.0).
After 3 months on these different diets, the rats were slightly anes-
thetized with ether, bled extensively, and perfused (15). Samples of
plasma, interscapular pads of brown adipose tissue (BAT), pituitary,
brain, cerebral cortex, cerebellum, liver, kidney, heart, lung, adrenals,
ovaries, and muscle (musculus quadriceps femoris) were dissected out
and frozen for the determination of T4 andT3.Aliquots of cerebral cortex,
BAT, liver, and lung were kept frozen at 80 C for the determination
of iodothyronine deiodinase activities.
The thyroid was dissected out, weighed, divided into three aliquots,
and kept frozen for the determination of type I 5deiodinase (D1) activity
and total I, T4, and T3 contents.
Determinations
I content.Thiswas determined in aliquots of thyroid glands, urine, or LID
by modifications of a chloric acid digestion procedure (16).
T4 and T3 in plasma and extrathyroidal tissues. Total T4 and T3 were mea-
sured by specific and highly sensitive RIAs, after extraction with meth-
anol and extensive purification of the iodothyronines, as detailed else-
where (15, 19). T4 and T3 concentrations in a given type of sample from
the five experimental groups were determined in the same extraction
run and in a single RIA for each hormone. To increase recovery of very
small tissues (i.e.pituitary, adrenals, ovaries), the initialmethanol extract
was purified directly through the resin columns, omitting the methanol-
chloroform extraction and back-extraction procedure.
The plasma free T4 (FT4) was calculated from the total T4 concentra-
tion and the percentage of added tracer amounts of [125I]T4 that was not
bound to serum transport proteins. The latter was determined by ul-
tracentrifugation of undiluted samples through Centricon-10 microcon-
centrators (Amicon GmbH, Witten, Germany) as detailed (20).
T4 and T3 in the thyroid. The contents of T4 and T3 in the thyroid were
measured separately in two different fractions to which we refer here,
respectively, as the “Free” T4 and “Free” T3 pools and as the “Total” T4
and T3 pools. When applied to the thyroid, the adjectives free and total
have a different meaning from plasma. In the thyroid, “Free” T4 and
TABLE 1. Estimation of the amounts of iodine available daily to
the thyroid of the rats from the different experiment B groups
Group Diet  supplements I, g/d per rata
LID LID 0.021b
LID LID 0.052b
LID  0.5 LID  0.5 g I/20 g 0.50
LID  1.0 LID  1.0 g I/20 g 1.0
LID  5.0 (controls) LID  5.0 g I/20 g 5.0
a Theoretically available for thyroidal uptake.
b Based on 24-h urinary I excretion data.
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“Free” T3 correspond to the iodothyronines present in the gland as
amino acids, no longer incorporated into proteins bypeptidic bonds, and
presumably available for secretion as hormones into the bloodstream.
“Total” T4 and T3 correspond to the iodothyronines residues still in-
corporated by peptidic bonds into thyroglobulin and other proteins. The
concentrations of “Free” T4 and “Free” T3 were obtained using the
methanol extracts of the thyroid homogenates, then processed as other
tissue extracts. The thyroid pools of “Total” T4 and T3 were measured
in methanol extracts of proteolytic hydrolysates of the pellets remaining
after the initial methanol extraction, as described (21)
Iodothyronine deiodinases. D1 activity was assayed in liver and lung ho-
mogenates using 400 nm rT3 and 2 mm dithiothreitol (DTT) for liver and
2 nm rT3 and 20mmDTT for lung in 100mm potassiumphosphate buffer
(pH 7.0) and 1 mm EDTA. The reaction time was 10 min for liver and
60 min for lung. D1 activity was also assayed in an aliquot of the thyroid
gland, using 0.8–1.0 m rT3 and 2 mm DTT for 10 min.
Type II 5-iodothyronine deiodinase (D2) activity was assayed in the
cerebral cortex and BAT using 2 nm T4  1 m T3 and 20 mm DTT in
the presence of 1 mm PTU, and the reaction time was 60 min.
All samples were homogenized in buffer containing 0.32 m sucrose,
10 mmHEPES (pH 7), and 1 (for D1) or 10 mm (for D2) DTT. Before each
assay [125I]rT3 or [
125I]T4 was purified, and the assays were performed
as described (22). The protein content was usually 150–200 g/tube for
most tissues but was 10-fold lower when liver or thyroid were assayed.
Circulating TSH. TSH was measured in plasma using immunoreactants
kindly provided by the Rat Pituitary Agency of the National Institute of
Diabetes, Digestive and Kidney Diseases (National Institutes of Health,
Bethesda, MD) as described elsewhere (16). Results are expressed in
weight equivalents of the National Institute of Diabetes and Digestive
and Kidney Diseases rTSH RP-3 preparation.
Drugs and reagents
T4, T3, 3,5-diiodothyronine, 6-N-propyl-2-tiouracil, and DTT were
obtained from Sigma Chemical Co. (St. Louis, MO). rT3 and 3,3-di-
iodothyronine were obtained from Henning Berlin GMBH (Berlin,
Germany).
High specific activity [131I]T4, [
125I]T3, [
125I]T4, and [
125I]rT3 (3000
Ci/g) were synthesized in our laboratory, as previously described
(19) and used for highly sensitive T4 and T3 RIAs, as recovery tracers for
plasma and tissues extractions, for the determination of plasma FT4, and
as substrates for D1 and D2.
Statistical analysis
One-way ANOVA and the protected least significant difference post
hoc test were used for multiple comparisons after validation of the
homogeneity of variances by the Bartlett-Box F test. Square root or
logarithmic transformations usually ensured homogeneity of variances
when this was not found with the raw data. Results are expressed as
means  sem. P  0.05 was considered significant in all comparisons.
Whenever it is stated that a difference was found between groups, it
implies that it is statistically significant. To be able to compare the degree
of changes in different parameters, all present results are expressed as
percentages of the mean value obtained for the LID  5.0 group (also
referred to as control, C, group), used as 100%. Multiple regressions and
partial correlation analyses between different parameters were also per-
formed. All calculations were done using the SPSS for Macintosh (ver-
sion 6.1.1; SPSS Inc., Chicago, IL).
Results
Experiment A
T4, T3, and TSH concentrations in plasma as well as the
concentrations of T4 and T3 in liver, brain, BAT, kidney, lung,
heart and skeletal muscle, and D2 activities in the cerebral
cortex were measured for the four groups. No differences
were found between the LID  I vs. LIDI groups. (For
detailed data, see table in supplemental data published on
The Endocrine Society’s Journals Online Web site at http://
endo.endojournals.org). The values found in the LID and
LID groups were significantly different from those of their
respective I-supplemented groups, LID  I and LID  I.
Therewere also significant differences between values found
in LID, compared with LID animals: plasma T3 and TSH,
liver, brain, kidney, andmuscle T4 and brain, lung, heart, and
muscle T3. Present results confirm that these very small
amounts of KClO4 do not have any detectable effect on thy-
roid hormone status when the I intake is adequate. On the
contrary, when the intake is very low, as in rats on LID,
thyroid hormone status is affected by the addition of 0.005%
of KClO4. The changes observed in LID rats vs. those on LID
are those that would be expected from a greater degree of ID.
Experiment B
Body weight. During the 3 months of treatments, the animals
on KI-supplemented LID, namely the LID  0.5, LID  1.0,
and LID  5.0 groups, increased similarly in body weight
(BW) by 64.4 2.0, 60.80 2.3, and 63.4 8.9 g, respectively.
The BW of the LID and LID groups increased significantly
less, by 51.5 2.0 and 36.2 2.7 g, respectively; the difference
between the latter two groups was also significant.
Thyroid gland. Figure 1 shows the results corresponding to the
thyroids of the five groups of experiment B. In this and
successive figures, the results have been normalized by ex-
pressing them as percentages of the mean values for the C
group, which are detailed in the figure legend.
All values shown in Fig. 1 for the LID  1.0 group were
already different from those of C animals including the
weight of the gland. The exceptions were the “Total” T3 to
“Total” T4 ratio and the activity of the D1 isoenzyme, which,
however, were different from C animals in LID  0.5 rats.
The weight of the thyroid increased up to 2.5-fold in the LID
rats, with a 2-fold increase being observed already in the LID
 1.0 group. The total I content of the gland decreased with
I intakes to an LID value thatwas 5%of that of theC animals.
The “Total” T4 and “Free” T4 also decreased markedly and
to a similar degree, reaching values of 1.5 and 1.8% of the C
value, respectively, in LID rats. In contrast, the “Total” T3
and “Free” T3 followed different patterns of change from
those observed for T4. After a marked decrease in LID 1.0,
compared with C animals, the “Total” T3 and “Free” T3
remained relatively constant despite a marked decrease in I
content. In LID rats, “Total” T3 and “Free” T3 were, respec-
tively, 8.5 and 23% of C value, much higher than those for
“Total” T4 and “Free” T4.
The ratios of both “Total” T3 and “Free” T3 to T4 increased
with decreasing I availability. The increase was, however,
much more marked (17-fold) for the ratio of “Free” T3 to T4
than that found for the ratio between “Total” T3 to T4 (7.5-
fold). This discrepancy may, at least partly, be accounted for
by the increase in D1 activity in the gland that could generate
“Free” T3 from the “Free” T4 but would not affect the iodo-
thyronine residues still incorporated by peptidic bonds into
thyroglobulin and other proteins.
Circulating T4, FT4, T3, and TSH
The changes occurring in the plasma of the different
groups of rats as I availability decreases are shown in Fig. 2.
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Plasma T4 is lower in LID  0.5 rats, compared with
controls (LID  5.0 group), but the difference was not sta-
tistically significant for the LID  1.0 animals. It further
decreases with increasing ID, reaching values in LID ani-
mals that were only 5% of C levels. FT4 is already decreased
in the LID 1.0 rats, compared with controls. The pattern of
changes in circulating T3 is quite different from that de-
scribed for T4. When the I intake decreases from LID  5.0
to LID  1.0, circulating T3 actually increases and then de-
creases again to C values in the LID  0.5 and LID groups.
Only in the LID animals did plasma T3 decrease, to 45% of
C values, a change that contrasts with the much more pro-
nounced decrease observed for circulating T4. As a conse-
quence, the T3 to T4 ratio is already increased above C values
in the LID  1.0 animals and further increased, more than
10-fold, in LID rats.
The mean circulating TSH value was higher in the LID 
1.0 animals, compared with C values (1.69  0.27 vs. 1.25 
0.16 ng rTSH RP-3/ml, respectively), but the difference did
not reach statistical significance (P  0.198) with present
sample sizes. It then increased progressively, 10-fold in LID,
compared with C animals, with a 7-fold increase in the LID
 0.5 group. PlasmaTSHwas negatively correlated to T4 (P
0.0012) but not to T3. Partial correlation analysis disclosed
that the relation between circulating TSH and T4 was inde-
pendent from T3 levels. Plasma TSH, however, was nega-
tively correlated to both pituitary T4 and T3 (P  0.000 for
both). Moreover, the degree of increase in TSH was unex-
pectedly small, even in the LID animals, comparedwith that
observed in rats with a similar degree of hypothyroxinemia
caused by primary thyroid failure, when T4 and T3 decrease
concomitantly, and circulating TSH is negatively and inde-
pendently correlated to both plasma T4 and T3. This is illus-
trated in Fig. 3, in which the changes in plasma TSH of the
present animals are comparedwith those of sex- andweight-
FIG. 2. Changes in plasma T4, FT4, and T3, in the plasma T3 to
plasma T4 ratio and circulating TSH in groups of rats with decreasing
I availability. All values are normalized by taking as 100% the mean
value of the corresponding variable in the controls (LID  5.0 group
of animals; T4: 22.9 3.9 ng/ml; FT4: 29.6 0.4 pg/ml; T3: 0.31 0.02
ng/ml; T3 to T4: 0.0135 0.0015; TSH: 1.25 0.16 ng rTSH RP-3/ml.
The meaning of symbols is the same as in Fig. 1.
FIG. 1. Changes in thyroid weight, total
iodine, T4, and T3 contents as well as T3 to
T4 ratios and total D1 activities in groups
of rats with a decreasing iodine intake.
“Total” T4 and T3 correspond to residues
incorporated into thyroglobulin and other
proteins by peptidic bonds, whereas
“Free” T4 and “Free” T3 are those present
in the gland as iodoamino acids, available
for secretion as hormones into the blood-
stream. All values are normalized by tak-
ing as 100% the mean value of the corre-
sponding variable in the controls (LID 
5.0 group of animals); weight: 23 1.2mg;
total I: 3.19  0.85 g/gland; “Total” T4
and T3: 4053  1297 and 212  47 ng/
gland; “Free” T4 and “Free” T3: 139  46
and 15.7 4.3 ng/gland; “Total” T3 to “To-
tal” T4 ratio: 0.045  0.007; “Free” T3 to
“Free” T4 ratio: 0.111  0.026; and D1:
1288  175 pmol/min per gland. Arrows
identify statistically significant increases
or decreases vs. the C group; & and &
identify statistically significant differ-
ences between the mean values for LID
and LID animals. The black arrows and
bold & correspond to the variables shown
as black bars, the white arrows and & to
those represented by white or striped
bars.
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paired animals that had been thyroidectomized (Tx) and
infused with different doses of T4 (15). The latter animals
showed plasma T3 changes parallel to those of T4, whereas
in the LID animals, T3 was still normal with plasma T4 and
FT4 levels that decreased to 25 and 15%, respectively, of C
values. Figure 3B shows that the plasma TSH increase is
blunted, more than 10-fold, in the LID animals, compared
with that observed in the Tx rats on T4.
Extrathyroidal tissues. Figure 4 illustrates the changes of the
concentrations of T4 and T3 in the liver, lung, brain, and BAT
occurring with decreasing I availability as well as the D1
activities in liver and lung and the D2 activities in brain and
BAT. In these tissues the concentrations of T4 decreased
following a pattern similar to that observed for plasma T4 or
FT4. The concentrations of T3 in liver and BAT followed
patterns similar to those of circulating T3, with an initial
increase from the LID  5.0 to LID  1.0 animals, normal
concentrations in the LID  0.5 and LID groups, and lower-
than-normal levels in the LID rats. In the lung the increase
in T3 concentrations persisted in all groups, including the
severely iodine-deficient LID animals that had a decreased
plasma T3. The pattern of changes for T3 in the brain were
different from those in liver, lung, and BAT: T3 decreased
with decreasing I availability and already did so in groups
with normal circulating T3 but low T4.
D1 activity in liver and lung showed only small changes
in the LID group, which did not persist in LID rats. In
contrast, the activity of D2 in the cerebral cortex and BAT
increased,with the differences between the LID 1.0 and the
C groups being statistically significant. The activities of the
D2 isoenzyme increased up to 9.5- and 7-fold in the cerebral
cortex and BAT, respectively, of LID, compared with C rats.
Figure 5 summarizes the changes observed in T4 and T3 in
cerebellum, pituitary, kidney, ovary, adrenal, heart, and
muscle with decreasing I availability. T4 decreased in all
FIG. 3. A, Relationships between plasma TSH and T4 in rats under
two different experimental conditions, namely experiment B and
those from a model of primary thyroid failure, namely Tx age- and
weight-paired rats infused with different doses of T4 (15). B, Results
on a log scale for TSH. Symbols in black identify groups with circu-
lating T3 that was decreased with respect to the corresponding C
value: the LID  5.0 group for the LID experiment B and intact rats
for the Tx  T4 experiment.
FIG. 4. Changes in the concentrations of T4
and T3 andD1 andD2 activities in the liver,
lung, brain, and BAT with decreasing I
availability. The values corresponding to
controls (LID  5.0 group) were: liver,
40.00  4.23 ng T4/g, 3.59  0.12 ng T3/g,
47.5  1.4 pmol/min per mg protein (D1);
lung, 8.08  1.35 ng T4/g, 1.71  0.15 ng
T3/g, 528  84 fmol/h per mg protein (D1);
brain, 1.81  0.09 ng T4/g, 2.44  0.20 ng
T3/g, 10.9  1.4 fmol/hmg protein (D2);
BAT, 2.04  0.21 ng T4/g, 3.02  0.18 ng
T3/g, 42  6 fmol/hmg protein (D2). The
meaning of symbols is the same as in Fig 1.
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these tissues following patterns similar to those of plasma
T4 or FT4. As already described for the liver, lung, brain,
and BAT (Fig. 4), the patterns of change in T3 varied greatly
among these other tissues. The greatest difference was
found between the patterns for the ovary and adrenal. In
the ovary there is a very remarkable increase of T3 in the
animals on LID  1.0, LID  0.5, and LID, compared with
LID  5.0, with an almost 2-fold increase in the LID  0.5
group. Ovarian T3 is still higher than that of the controls,
even in the LID group, in which serum T3 was decreased
by about 50%.1 On the contrary, T3 in the adrenal decreases
steadily with decreasing I availability, almost in parallel to
adrenal T4, and more markedly than circulating T3: values
in the adrenals of LID animals are only 17% of those of the
C group, whereas plasma T3 is still 46%. As already de-
scribed above for the lung, the muscle and heart main-
tained normal T3 concentrations, even in LID animals. In
these animals, T3 decreased only in the cerebellum, pitu-
itary, and kidney and did so only to 67–73% of C values,
less than the decrease in circulating T3.
Discussion
The experimental design
The I intake of the female rats on LID  5.0 g/d was
sufficient for adequate growth. The I content of the stock
pelleted diet used in our breeding facilities was determined
and found to vary between 3 and 7 g I per 20 g. The daily
thyroidal secretion rate of strain-, sex-, and age-paired rats on
this diet is estimated as being equivalent to 0.9 g T4  0.15
g T3 per 100 g BW (23), which together contain 0.59 g I
from T4  0.09 g I from T3  0.68 g of I per 100 g BW.
Present rats weighed less than 300 g at the end of the ex-
periment, and turnover of hormonal I should be 2.04 g I or
less per day. Thus, a daily supplement of 5.0 g I ought to
cover physiological requirements, a conclusion in agreement
with previous findings by others (8), namely that an I intake
of 3 g/d or higher already ensures maximum levels of T4
and T3 in rat tissues.
The composition of the LID was the same for the five
groups of experiment B,with the I content of the daily rations
being the single controlled variable from the LID 5.0 to the
LID group. Results of experiment A also support that the
amount of I available to the thyroid is the single variable
between the LID group and the other animals because the
very low amount of added KClO4 (1 mg/d) did not have, per
se, any effect on thyroid hormone status in the I-sufficient
(LID  I) groups.
Our experimental design therefore avoided differences
between the experimental groups that could be related to sex,
strain, and nutritional composition of the diet, all of which
are known to affect thyroid hormone status.
As far as could be assessed from the increment in BW, the
decrease in I availability did not affect the general condition
of the animals until it became severe (LID and LID groups).
Despite their smaller increase in BW, even the animals of the
LID group did not show clinical signs of hypothyroidism
comparable with those of animals that are thyroidectomized
and stop growing within a few weeks. This is in agreement
with previous results from this laboratory using the same
strain of animals and type of LID (16, 18).
1As indicated in Materials and Methods, the ovarian extracts were
purified by a modified protocol to increase recovery of the iodothy-
ronines. The possibility that interfering substances had been carried over
into the T3 RIA samples was tested. Extracts of the ovaries from the LID
animals were tested at six different successive 2-fold dilutions. The plot
of the specifically antibody-bound tracer vs. the log of the aliquot volume
was parallel to that of obtained with the T3 standard. This result con-
firmed that T3, and not artifacts, was being measured in the ovaries.
FIG. 5. Changes in the concentrations
of T4 and T3 in the cerebellum, pitu-
itary, kidney, ovary, adrenal, heart, and
muscle with decreasing I availability.
The upper left panel shows the corre-
sponding plasma concentrations for
comparison. The values corresponding
to controls (LID  5.0 group) were: cer-
ebellum, 3.98 0.31 ng T4/g and 2.18
0.14 ng T3/g; pituitary, 54  10 pg T4,
93  6 pg T3; kidney, 20.70  0.80 ng
T4/g, 7.08  0.79 ng T3/g; ovary, 1.18 
0.07 ng T4, 0.15  0.01 ng T3; adrenal,
0.30  0.04 ng T4, 0.20  0.07 ng T3;
heart, 3.82  0.49 ng T4/g, 1.54  0.18
ng T3/g; muscle, 1.91  0.19 ng T4/g,
1.18  0.06 ng T3/g. The values shown
for the pituitary, ovary, and adrenal are
the total T4 and T3 contents because the
recorded weights were considered un-
reliable. The meaning of symbols is the
same as in Fig. 1.
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Response to different grades of ID
Present findings fully confirm that the mechanisms in-
volved are clearly dependent on the degree of I availability
to the thyroid. For this reason, we will discuss them sepa-
rately for animals with mild (LID  1.0 group), moderate
(LID 0.5 group), severe (LID group), and very severe (LID
group) ID (Table 2).
Mild ID: LID  1.0 group
Intrathyroidal response mechanisms predominate when
the daily I intake is reduced from 5 to 1 g, no longer suf-
ficient to compensate for daily requirements. This is con-
firmed by a notable increase in thyroid weight that already
accounts for a major part of the total increase observed with
decreasing I availability. There is also an increase in the
thyroid “Free” T3 to “Free” T4 ratios. We wish to point out
that these changes occur without an increase in circulating
TSH. This finding initially surprised us until we reviewed
earlier studies in rats on an I intake similar to that of our LID
 1.0 group (6, 9, 12, 24–27): An increase in vascularity, blood
flow, I trapping, acinar cell height, and hyperplasia of the
gland have all been described to occur without any signif-
icant increase in circulating TSH. The same occurs with the
changes in intrathyroid I metabolism, which lead to a pref-
erential synthesis and secretion of T3 over T4, and an in-
creased T3 to T4 ratio in the circulation. These changes are
correlated to the degree of I depletion and are the opposite
of the TSH-independent response of the thyroid exposed to
a sudden I excess (28). Their independence from serum TSH
has been confirmed in hypophysectomized rats fed LID (24,
26). Our present data, therefore, confirm an important role of
thyroid autoregulatory responses in the efficient adaptation
to a mild degree of ID.
The mechanism(s) involved in these autoregulatory pro-
cesses have not yet been identified. It is possible that a re-
duced availability of I decreases the thyroid content of io-
dolactones, which are involved in TSH-independent
hyperplasia of the gland (29). A possible role of the sodium/
iodide symporter in ID has hardly been addressed experi-
mentally in rats, with the exception of a report (30) that its
expression increased in the thyroid of ID fetuses with normal
plasma TSH.
Extrathyroidal response mechanisms involved in these
mildly ID rats are less evident than the intrathyroidal auto-
regulatory ones that result in the higher plasma T3 to T4 ratio,
resultingmainly from the preferential secretion of T3 over T4.
The patterns of the changes in the concentrations of T4 and
T3 in the tissues studied here, however, appear to be tissue
specific and not easily predictable from the change in circu-
lating T4 and T3. A similar conclusion was reached years ago
by Heninger and Albright (8), who measured the concen-
trations of T4 and T3 in several tissues of rats on a diet with
an I content similar to that of the present LID  1.0 group:
they also found that T3 increased in plasma andmany tissues
but not all (i.e. the brain) and that the degree of change was
tissue specific. Extrathyroidal responses appear to be in-
volved, as shown by the increased D2 activities in brain and
BAT.
The increase in T3 concentration in many of the tissues
studied here, such as the liver, lung, kidney, and muscle,
were predictable from their known major dependency on
plasma-derived T3, Similarly, the lack of an increase in the
brain, cerebellum, and pituitary would be expected from
their dependency on locally generated T3 byD2 deiodination
of T4 (31). BAT, however, presented some unexpected fea-
tures, being usually included among the tissues that derive
intracellular T3 locally from T4 by D2. In these tissues D2
activity increases when T4 decreases. Indeed, this is what
occurred in the BAT of mildly I-deficient rats (see Fig. 4), as
expected. Not anticipated, however, was the marked in-
crease in BAT T3, comparable with that in plasma, and not
observed in other experimental models (32). Whichever the
mechanisms involved, the increased generation of T3 in BAT
may actually contribute, together with the preferential se-
cretion of T3 by the gland, to the marked increase in systemic
T3 of the LID  1.0 rats (33).
An increased activity of D2 in the brain had been expected
from the decrease in brain T4, a response amply shown in rats
on LID with markedly decreased plasma T4 (34), but present
results show that D2 responds to a muchmilder degree of ID
than previously described.
The lack of increase of T3 content of the adrenals had also
not been anticipated because this tissue has been considered
dependent on serum-derived T3 (31, 32). The marked in-
crease in the concentration of T3 in the ovary, a tissue not
previously included in other studies (31), suggests its de-
pendence on plasma-derived T3.
In summary, both intra- and extrathyroidal mechanisms
are involved in the response of the rat to mild ID: the former
are autoregulatory and very effective in avoiding T3 defi-
ciency inmost tissues, and the latter occur in tissues in which
D2 is important for local generation of T3. In mild ID, hy-
pothyroidism, as inferred from the concentrations of T3, is
avoided in all tissues studied.
TABLE 2. Mean values of thyroid weight and I content and circulating T4, FT4, T3, and TSH, expressed as percent of the control values
(LID  5.0 group), used in the present study to define different grades of ID
Grade of ID Group I, g/da Thyroid weight Thyroid I Plasma T4 Plasma FT4 Plasma T3 Plasma TSH
No ID LID  5.0 (controls) 5.0 100 100 100 100 100 100
Mild LID  1.0 1.0 1871 612 82 572 1391 135
Moderate LID  0.5 0.50 1961 232 512 322 105 5931
Severe LID 0.052 2041 52 252 152 96 6341
Very severe LID 0.021 2481 62 52 22 462 9761
a Estimated values; see Table 1.
1 and 2, Significant increase or decrease vs. LID  5.0 group.
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Moderate ID: LID  0.5 group
There is a further decrease in the I, “Total” T4, and “Total”
T3 contents of the thyroid to about 25% of control values. A
new intrathyroidal-adaptive mechanism becomes evident,
namely an increase inD1 activity,which could deiodinate the
“Free” T4 fraction and the plasma T4 entering the gland. This
could prevent a further decrease of the “Free” T3 content and
contribute to maintenance of a normal plasma T3 as effec-
tively as, or more than, the preferential intrathyroidal syn-
thesis of T3. We do not know whether the increase in D1
activity is an autoregulatory mechanism or the consequence
of the increase in circulating TSH observed in this group. In
contrast, thyroid weight is hardly affected by the increase in
TSH, a finding consistent with the concept that thyroid
growth is mainly determined by autoregulatory processes in
both mild and moderate ID.
Plasma T3 was no longer elevated in the moderately ID
animals but remained normal despite a 50% decrease of T4.
T3 deficiency was prevented in tissues that derive T3
mostly from plasma and also in BAT and cerebellum.
Unexpectedly, despite normal T3 and very low T4 in
plasma, some tissues maintained high T3 levels, most no-
tably the lung, ovary, and muscle. The underlying mech-
anisms have not been identified: in the lung, for instance,
an increase in D1 activity was not involved. In the brain
T3 decreased, despite the increased D2 activity, and so did
pituitary T3. As already noted in the mild ID group, T3
decreased in the adrenal in parallel with T4.
In summary, the case of moderate ID, intra- and extra-
thyroidal responses are still adequate to prevent lowT3 levels
in plasma andmost tissues, despite a reduction of the I intake
to 25% of that of controls. Some tissues even maintain ele-
vated T3 concentrations, whereas others are markedly (ad-
renal) or moderately (brain and pituitary) T3 deficient.
Severe I deficiency: LID group
The intra-thyroidal response mechanisms operative in
previous groups continue to minimize the effects of a further
marked decrease of the I intake and circulating T3 remains
normal. A role is also likely to be played by the marked
increase in thyroid D1 activity, which would avoid a further
decrease of the “Free” T3 concentration. This increase occurs
without a further concordant increase in TSH; it might be an
autoregulatory process, but the influence of the higher than
normal serum TSH cannot be excluded.
Despite a major decrease in plasma T4 to 25% of control
values, T3 concentrations not only remained normal in
plasma, but also inmost tissues. The role of a further increase
of D2 activity is evident in those tissues where it was mea-
sured. Again, the most unexpected and striking results are
those obtained for the concentration of T3 in the ovary and
lung, where it is much higher, and in the adrenal, where it
is much lower, than expected from the normal circulating T3.
In summary, despite a 100-fold decrease in I availability,
a combination of intra- and extrathyroidal adaptive mech-
anism still mitigates T3 deficiency and presumably hypothy-
roidism in most but not all tissues.
Very severe ID: LID group
Intrathyroidal adaptive mechanisms are no longer suffi-
cient in LID rats to ensure a normal T3, which decreases in
plasma to 45% of C values, and also in many tissues that
depend on plasma-derived T3, including the liver. Despite
the marked increase in D2 activity, the brain, cerebellum,
pituitary, and BAT are T3 deficient, probably because of the
very low availability of plasma T4 that has decreased to 5%
of normal values. We have previously shown that the brain,
pituitary, and liver of such animals are indeed hypothyroid,
as assessed from several biological end points of thyroid
hormone action (11). Tissue T3, however, decreases less than
would be expected from the circulating T3 level (adrenals
again excepted), and some tissues continue having normal
(muscle, heart) or even elevated (lung, ovary) T3
concentrations.
In summary, the threshold I availability belowwhichmost
tissues are T3 deficient appears to be reached when the intra-
and extrathyroidal adaptive mechanisms are no longer ca-
pable of ensuring a normal circulating T3. But even then,
adaptive mechanisms that protect most tissues, and espe-
cially the heart, muscle, and ovary, become operative from
the degree of T3 that would be expected from the decrease in
plasma T3.
In the present study, we did not measure the activities of
the iodothyronine deiodinase isoenzymes in most tissues or
activities of other enzymes, such as sulfotransferases and
sulfatases, or the concentrations of T4 and T3 sulfates (35) that
might regulate the local availability of T3 in different tissues.
Also not investigated were the possible adaptive roles of
changes in tissue uptake and/or exit rates of the iodothy-
ronines (36) that might further minimize T3 deficiency in
tissues. In this context, it is interesting that tissue to plasma
T3 and T4 ratioswere increased in some tissues of the LID rats
and in most of those of the LID group (data not shown).
T4, T3, and TSH feedback in ID
We wish to draw attention to the findings illustrated in
Figs. 2 and 3 that clearly show that in conditions of decreased
I availability, plasma-derived T3 plays a very decisive role in
the regulation of circulating TSH. The TSH response is one
tenth, or less, that observed in rats with primary thyroid
failure and comparable degrees of hypothyroxinemia but
with parallel decreases in plasma T3 (15).We believe it is very
important and probably quite relevant for inhabitants of
areas with mild and moderate ID to realize that a normal
plasma TSH does not exclude, per se, a selective T3 deficiency
in tissues, such as the brain, that are affected by the decreased
availability of T4 as substrate for the local generation of T3.
There are also other experimental situations, in which serum
TSH is more closely correlated to circulating T3 than T4 (37).
Such findings also point to a more important role of plasma-
derived T3 in the inhibition of TSH release, compared with
that of T3 generated locally from T4 by D2.
Present results constitute a clear contradiction to the pre-
vious idea that findings in I-deficient animals and humans,
in which a close negative correlation is found between cir-
culating TSH and T4, despite normal T3, are a prime example
of the beneficial adaptive role of the local generation of T3
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from T4: it was, moreover, difficult to explain the adaptive
advantage of the observed increase in D2 activity in the
pituitary because it would increase locally generated T3,
shutting down the compensatory mechanism, namely an
increase in plasma TSH.
Conclusion
ID rats are endowed with numerous and very efficient
adaptive mechanisms, most of which require a fully func-
tioning normal thyroid gland, and are thus lost in animals
with primary thyroid failure. ID rats are often considered to
be either hypothyroid, because of their low circulating T4 and
increased TSH, or euthyroid, because of their normal (or
increased) plasma T3, but present results stress that neither
assumption is correct: thyroid hormone status is not only
related to the degree of depletion of I availability to the
thyroid but is also eminently tissue specific. As discussed
elsewhere (15), few tissue-specific direct effects of thyroid
hormone action are available, and we measured the concen-
tration of T3 in the tissues as a first step in assessing their
thyroid hormone status. With a moderate, or even severe, I
deficiency,most tissues depending on plasma T3would have
normal, or even slightly elevated, T3 concentrations, most
notably the ovary, lung, heart, and muscle. However, those
tissues that depend to an appreciable extent on T4 for the
local generation of T3 are protected from T3 deficiency to a
lesser degree. As a consequence, in the latter type of tissue,
thyroid hormone-sensitive functions are more likely to be
affected than those characteristic of tissues depending on
plasma-derived T3. Such is the case of the brain, for instance,
and cerebral functions may already be impaired in moderate
ID because brain T3 is already decreased. In the mildly ID
group, inwhichplasmaTSHwasnormal andplasmaFT4was
slightly decreased, total brain T4 was decreased and D2 ac-
tivity was increased. This prevented a decrease of T3 in the
total brain but not necessarily in all brain areas (13, 38).
Present results also indicate that the degree of increase in D2
activity in different cerebral structures of ID rats does not
permit, per se, conclusions to be drawn regarding their pro-
tection from T3 deficiency because the latter also involves the
amount of T4 available in each area (13).
Circulating T3 has to decrease before many T3-dependent
tissues become T3 deficient. This appears to occur when
circulating T4 decreases from 25 to 5% of normal values. But
even under such conditions, the many known and as-yet-
undefined intra- and extrathyroidal adaptive mechanisms
are efficient enough to maintain euthyroidism in muscle and
heart and even slightly elevated T3 in lung and ovary. The
findings in the ovary may underlie the observation that even
very severely I-deficient animals are easily mated, do not
show decreased fertility, and bear litters of normal size (16,
18), in contrast to Tx or goitrogen-treated hypothyroid fe-
males (19).
Possible implications for man
As already pointed out in the introductory text, the present
study is relevant only for inhabitants of areas in which ID is
the sole cause of goiter but not for areas in which other
environmental factors may lead to destruction of the gland
and therefore to clinical hypothyroidism.We believe present
results in mild and moderate grades of decreased I avail-
ability are especially relevant for man because such condi-
tions are still widespread inWestern industrialized countries
(39).
Many of the findings in rats, described here and by others,
have also been described in people from areas with an ad-
equate I intake who are changed to an I-deficient diet or for
inhabitants of the ID areas defined above. Thus, for instance,
the gland respondswithin a fewdayswith a striking increase
in blood flow, occurring before any change is detected in
plasma T4 or TSH (40). Increased I trapping and circulating
T3 to T4 ratios have also been shown (3). In simple sporadic
goiter, the increase in thyroid volume occurs without a nec-
essary increase in circulating TSH (41–44). Even in very
severe ID, the increase in circulating TSH is markedly
blunted, compared with that usually observed in hypothy-
roid patients (43–46). Missler et al. (45) reported that in 304
children from an ID area, 60% had an enlarged gland, but
only 9% had TSH greater than 4.5 mU/liter. In the seminal
studies by Glinoer (47) on thyroid function in pregnant
women from a population with mild to moderate ID, TSH
levels above the normal reference range were hardly ever
found at any stage of pregnancy, even among the women
with the lowest first-trimester FT4 levels. The same was ob-
served in pregnant women from an area with very mild ID
(48, 49).
Western-trained physicians dealing mostly with patients
with primary thyroid failure rely on an increased circulating
TSH for their classification of overt or subclinical hypothy-
roidism and are often unfamiliar with the concept of hypo-
thyroxinemia: a decreased T4 without an increase of TSH
above normal. The TSH-independent autoregulatory mech-
anisms controlling thyroid function in ID are often over-
looked, as these mechanisms are better known in the case of
iodine excess. The present experimental data obtained with
mild to moderate grades of ID stress the primary importance
of autoregulatory mechanisms that protect many tissues
from overt T3 deficiency. Even in very severe ID (2), people
are able to sustain heavy physical work and have normal
cardiac function, observations that might be related to the
present findings inmuscle and heart, whichmaintain normal
T3 concentrations, even in the LID group.
As discussed elsewhere in more detail (49), it is inaccurate
to assume that inhabitants of ID areas are clinically hypo-
thyroid individuals. The present experimental model sup-
ports the epidemiological findings that inhabitants of ID
areas are not clinically hypothyroid individuals because their
normal circulating T3 ensures normal T3 concentration in
most tissues. But, as shown here, this might not avoid se-
lective T3 deficiency of those tissues, such as the brain, that
dependmostly on T4 for their intracellular T3 supply. Inman,
this might already negatively affect mental functions in mild
ID (5, 39, 46, 49–51), in which inhabitants are often described
as dull (52).
It is often assumed that eradication of severe ID is enough
to avoid the most important IDD, including those affecting
mental processes. Present experimental results obtained in
moderately ID rats stress that this is not so, and countries
with areas of moderate ID should actively correct it: an im-
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portant proportion of their inhabitants, and their future prog-
eny, may still suffer from easily preventable impairments of
mental functions and the consequent socioeconomic impli-
cations (49) as well as the increased incidence of thyroid
disorders ensuing from thyroid hyperplasia.
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